UBS Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-71,942
| Closed | -$5.41M | – | 10468 |
|
|
2022
Q2 | $5.41M | Sell |
71,942
-2,291
| -3% | -$172K | ﹤0.01% | 1717 |
|
|
2022
Q1 | $1.99M | Sell |
74,233
-46,405
| -38% | -$1.25M | ﹤0.01% | 2655 |
|
|
2021
Q4 | $5.76M | Buy |
120,638
+83,495
| +225% | +$3.98M | ﹤0.01% | 1972 |
|
|
2021
Q3 | $2.47M | Buy |
37,143
+28,894
| +350% | +$1.92M | ﹤0.01% | 2600 |
|
|
2021
Q2 | $643K | Sell |
8,249
-33,543
| -80% | -$2.61M | ﹤0.01% | 3575 |
|
|
2021
Q1 | $3.95M | Buy |
41,792
+41,006
| +5,217% | +$3.88M | ﹤0.01% | 2173 |
|
|
2020
Q4 | $96K | Sell |
786
-1,319
| -63% | -$161K | ﹤0.01% | 4736 |
|
|
2020
Q3 | $184K | Buy |
2,105
+763
| +57% | +$66.7K | ﹤0.01% | 4026 |
|
|
2020
Q2 | $87K | Sell |
1,342
-5,010
| -79% | -$325K | ﹤0.01% | 4589 |
|
|
2020
Q1 | $283K | Sell |
6,352
-14,023
| -69% | -$625K | ﹤0.01% | 3639 |
|
|
2019
Q4 | $1.27M | Sell |
20,375
-6,739
| -25% | -$420K | ﹤0.01% | 3134 |
|
|
2019
Q3 | $1.02M | Buy |
27,114
+25,022
| +1,196% | +$940K | ﹤0.01% | 3181 |
|
|
2019
Q2 | $85K | Buy |
+2,092
| New | +$85K | ﹤0.01% | 4647 |
|